1
|
Ortega-Martinez A, Rogers D, Anderson J, Farzam P, Gao Y, Zimmermann B, Yücel MA, Boas DA. How much do time-domain functional near-infrared spectroscopy (fNIRS) moments improve estimation of brain activity over traditional fNIRS? NEUROPHOTONICS 2023; 10:013504. [PMID: 36284602 PMCID: PMC9587749 DOI: 10.1117/1.nph.10.1.013504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Accepted: 09/26/2022] [Indexed: 06/16/2023]
Abstract
SIGNIFICANCE Advances in electronics have allowed the recent development of compact, high channel count time domain functional near-infrared spectroscopy (TD-fNIRS) systems. Temporal moment analysis has been proposed for increased brain sensitivity due to the depth selectivity of higher order temporal moments. We propose a general linear model (GLM) incorporating TD moment data and auxiliary physiological measurements, such as short separation channels, to improve the recovery of the HRF. AIMS We compare the performance of previously reported multi-distance TD moment techniques to commonly used techniques for continuous wave (CW) fNIRS hemodynamic response function (HRF) recovery, namely block averaging and CW GLM. Additionally, we compare the multi-distance TD moment technique to TD moment GLM. APPROACH We augmented resting TD-fNIRS moment data (six subjects) with known synthetic HRFs. We then employed block averaging and GLM techniques with "short-separation regression" designed both for CW and TD to recover the HRFs. We calculated the root mean square error (RMSE) and the correlation of the recovered HRF to the ground truth. We compared the performance of equivalent CW and TD techniques with paired t-tests. RESULTS We found that, on average, TD moment HRF recovery improves correlations by 98% and 48% for HbO and HbR respectively, over CW GLM. The improvement on the correlation for TD GLM over TD moment is 12% (HbO) and 27% (HbR). RMSE decreases 56% and 52% (HbO and HbR) for TD moment compared to CW GLM. We found no statistically significant improvement in the RMSE for TD GLM compared to TD moment. CONCLUSIONS Properly covariance-scaled TD moment techniques outperform their CW equivalents in both RMSE and correlation in the recovery of the synthetic HRFs. Furthermore, our proposed TD GLM based on moments outperforms regular TD moment analysis, while allowing the incorporation of auxiliary measurements of the confounding physiological signals from the scalp.
Collapse
Affiliation(s)
| | - De’Ja Rogers
- Boston University Neurophotonics Center, Boston, Massachusetts, United States
| | - Jessica Anderson
- Boston University Neurophotonics Center, Boston, Massachusetts, United States
| | - Parya Farzam
- Boston University Neurophotonics Center, Boston, Massachusetts, United States
| | - Yuanyuan Gao
- Boston University Neurophotonics Center, Boston, Massachusetts, United States
| | - Bernhard Zimmermann
- Boston University Neurophotonics Center, Boston, Massachusetts, United States
| | - Meryem A. Yücel
- Boston University Neurophotonics Center, Boston, Massachusetts, United States
| | - David A. Boas
- Boston University Neurophotonics Center, Boston, Massachusetts, United States
| |
Collapse
|
2
|
Anthropomorphic Polydimethylsiloxane silicone-based phantom for Diffuse Optical Imaging. Heliyon 2022; 8:e10308. [PMID: 36033332 PMCID: PMC9404336 DOI: 10.1016/j.heliyon.2022.e10308] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Revised: 07/06/2022] [Accepted: 08/11/2022] [Indexed: 11/24/2022] Open
Abstract
This work presents a method for constructing phantoms suitable for diffuse optical mammography. They are based on Polydimethylsiloxane silicones, with the characteristic of being anthropomorphic, and having similar mechanical and optical properties as a real breast. These phantoms are useful for testing the performance of diffuse optical imaging devices in the near infrared, both in transmittance and reflectance geometries, since they can be constructed containing inclusions, to simulate breast tumors. An alternative component to be used as scattering agent, that is easier to handle than traditional scattering agents, is also studied. The optical properties of the phantoms were tested varying the concentration of scattering and absorbing agents, while their mechanical properties were modified by adding a silicone fluid to the basic mixture. Finally, the phantoms were tested by Diffuse Optical Imaging experiments, and these images were compared to the ones obtained by conventional ultrasound techniques. Results show that the constructed anthropomorphic phantoms properly reproduce the optical and mechanical characteristics of human breasts, and are suitable to be used in Diffuse Optical Imaging. We constructed anthropomorphic phantoms for Diffuse Optical Imaging. They simulate the optical and mechanical characteristics of a human breast. A new scattering agent was successfully introduced. Results of Diffuse Optical images are compared to Ultrasound images.
Collapse
|
3
|
Jiang J, Costanzo Mata AD, Lindner S, Charbon E, Wolf M, Kalyanov A. 2.5 Hz sample rate time-domain near-infrared optical tomography based on SPAD-camera image tissue hemodynamics. BIOMEDICAL OPTICS EXPRESS 2022; 13:133-146. [PMID: 35154859 PMCID: PMC8803024 DOI: 10.1364/boe.441061] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Revised: 11/12/2021] [Accepted: 11/15/2021] [Indexed: 05/31/2023]
Abstract
Time-domain near-infrared optical tomography (TD NIROT) techniques based on diffuse light were gaining performance over the last years. They are capable of imaging tissue at several centimeters depth and reveal clinically relevant information, such as tissue oxygen saturation. In this work, we present the very first in vivo results of our SPAD camera-based TD NIROT reflectance system with a temporal resolution of ∼116 ps. It provides 2800 time of flight source-detector pairs in a compact probe of only 6 cm in diameter. Additionally, we describe a 3-step reconstruction procedure that enables accurate recovery of structural information and of the optical properties. We demonstrate the system's performance firstly in reconstructing the 3D-structure of a heterogeneous tissue phantom with tissue-like scattering and absorption properties within a volume of 9 cm diameter and 5 cm thickness. Furthermore, we performed in vivo tomography of an index finger located within a homogeneous scattering medium. We employed a fast sampling rate of 2.5 Hz to detect changes in tissue oxygenation. Tomographic reconstructions were performed in true 3D, and without prior structural information, demonstrating the powerful capabilities of the system. This shows its potential for clinical applications.
Collapse
Affiliation(s)
- Jingjing Jiang
- Biomedical Optics Research Laboratory (BORL), Dept. of Neonatology, University of Zurich / University Hospital Zurich, Switzerland
| | - Aldo Di Costanzo Mata
- Biomedical Optics Research Laboratory (BORL), Dept. of Neonatology, University of Zurich / University Hospital Zurich, Switzerland
| | - Scott Lindner
- Biomedical Optics Research Laboratory (BORL), Dept. of Neonatology, University of Zurich / University Hospital Zurich, Switzerland
- Advanced Quantum Architecture (AQUA) laboratory, School of Engineering, EPFL Lausanne, Switzerland
- now with ams OSRAM, Rüschlikon, Zurich, Switzerland
| | - Edoardo Charbon
- Advanced Quantum Architecture (AQUA) laboratory, School of Engineering, EPFL Lausanne, Switzerland
| | - Martin Wolf
- Biomedical Optics Research Laboratory (BORL), Dept. of Neonatology, University of Zurich / University Hospital Zurich, Switzerland
| | - Alexander Kalyanov
- Biomedical Optics Research Laboratory (BORL), Dept. of Neonatology, University of Zurich / University Hospital Zurich, Switzerland
| |
Collapse
|
4
|
Real-Time Dual-Wavelength Time-Resolved Diffuse Optical Tomography System for Functional Brain Imaging Based on Probe-Hosted Silicon Photomultipliers. SENSORS 2020; 20:s20102815. [PMID: 32429158 PMCID: PMC7287927 DOI: 10.3390/s20102815] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Revised: 05/11/2020] [Accepted: 05/12/2020] [Indexed: 01/12/2023]
Abstract
Near-infrared diffuse optical tomography is a non-invasive photonics-based imaging technology suited to functional brain imaging applications. Recent developments have proved that it is possible to build a compact time-domain diffuse optical tomography system based on silicon photomultipliers (SiPM) detectors. The system presented in this paper was equipped with the same eight SiPM probe-hosted detectors, but was upgraded with six injection fibers to shine the sample at several points. Moreover, an automatic switch was included enabling a complete measurement to be performed in less than one second. Further, the system was provided with a dual-wavelength (670 nm and 820 nm) light source to quantify the oxy- and deoxy-hemoglobin concentration evolution in the tissue. This novel system was challenged against a solid phantom experiment, and two in-vivo tests, namely arm occlusion and motor cortex brain activation. The results show that the tomographic system makes it possible to follow the evolution of brain activation over time with a 1s-resolution.
Collapse
|
5
|
Abstract
This article reviews the past and current statuses of time-domain near-infrared spectroscopy (TD-NIRS) and imaging. Although time-domain technology is not yet widely employed due to its drawbacks of being cumbersome, bulky, and very expensive compared to commercial continuous wave (CW) and frequency-domain (FD) fNIRS systems, TD-NIRS has great advantages over CW and FD systems because time-resolved data measured by TD systems contain the richest information about optical properties inside measured objects. This article focuses on reviewing the theoretical background, advanced theories and methods, instruments, and studies on clinical applications for TD-NIRS including some clinical studies which used TD-NIRS systems. Major events in the development of TD-NIRS and imaging are identified and summarized in chronological tables and figures. Finally, prospects for TD-NIRS in the near future are briefly described.
Collapse
|
6
|
Ohmae E, Yoshizawa N, Yoshimoto K, Hayashi M, Wada H, Mimura T, Suzuki H, Homma S, Suzuki N, Ogura H, Nasu H, Sakahara H, Yamashita Y, Ueda Y. Stable tissue-simulating phantoms with various water and lipid contents for diffuse optical spectroscopy. BIOMEDICAL OPTICS EXPRESS 2018; 9:5792-5808. [PMID: 30460162 PMCID: PMC6238899 DOI: 10.1364/boe.9.005792] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/15/2018] [Revised: 10/12/2018] [Accepted: 10/12/2018] [Indexed: 05/17/2023]
Abstract
We introduced a method for producing solid phantoms with various water-to-lipid ratios that can simulate the absorption, and to some extent the scattering characteristics of human breast tissue. We also achieved phantom stability for a minimum of one month by solidifying the emulsion phantoms. The characteristics of the phantoms were evaluated using the six-wavelength time-domain diffuse optical spectroscopy (TD-DOS) system we developed to measure water and lipid contents and hemoglobin concentration. The TD-DOS measurements were validated with a magnetic resonance imaging system.
Collapse
Affiliation(s)
- Etsuko Ohmae
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Nobuko Yoshizawa
- Department of Diagnostic Radiology and Nuclear Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Pref., 431-3192, Japan
| | - Kenji Yoshimoto
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Maho Hayashi
- Department of Diagnostic Radiology and Nuclear Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Pref., 431-3192, Japan
| | - Hiroko Wada
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Tetsuya Mimura
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Hiroaki Suzuki
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Shu Homma
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Norihiro Suzuki
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Hiroyuki Ogura
- Department of Breast Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Pref., 431-3192, Japan
| | - Hatsuko Nasu
- Department of Diagnostic Radiology and Nuclear Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Pref., 431-3192, Japan
| | - Harumi Sakahara
- Department of Diagnostic Radiology and Nuclear Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Pref., 431-3192, Japan
| | - Yutaka Yamashita
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| | - Yukio Ueda
- Central Research Laboratory, Hamamatsu Photonics K. K., 5000, Hirakuchi, Hamakita-ku, Hamamatsu City, Shizuoka Pref., 434-8601, Japan
| |
Collapse
|
7
|
Milej D, Abdalmalak A, Janusek D, Diop M, Liebert A, St Lawrence K. Time-resolved subtraction method for measuring optical properties of turbid media. APPLIED OPTICS 2016; 55:1507-13. [PMID: 26974605 DOI: 10.1364/ao.55.001507] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Near-infrared spectroscopy is a noninvasive optical method used primarily to monitor tissue oxygenation due to the absorption properties of hemoglobin. Accurate estimation of hemoglobin concentrations and other light absorbers requires techniques that can separate the effect of absorption from the much greater effect of light scattering. One of the most advanced methods is time-resolved near-infrared spectroscopy (TR-NIRS), which measures the absorption and scattering coefficients of a turbid medium by modeling the recorded distribution time of flight of photons. A challenge with TR-NIRS is that it requires accurate characterization of the dispersion caused by the system. In this study, we present a method for circumventing this problem by applying statistical moment analysis to two time-of-flight distributions measured at separated source-detector distances. Simulations based on analytical models and Monte Carlo code, and tissue-mimicking phantoms, were used to demonstrate its accuracy for source-detector distances typically used in neuroimaging applications. The simplicity of the approach is well suited to real-time applications requiring accurate quantification of the optical properties of a turbid medium.
Collapse
|
8
|
Erickson-Bhatt SJ, Roman M, Gonzalez J, Nunez A, Kiszonas R, Lopez-Penalver C, Godavarty A. Noninvasive Surface Imaging of Breast Cancer in Humans using a Hand-held Optical Imager. Biomed Phys Eng Express 2015; 1. [PMID: 27366327 DOI: 10.1088/2057-1976/1/4/045001] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
X-ray mammography, the current gold standard for breast cancer detection, has a 20% false-negative rate (cancer is undetected) and increases in younger women with denser breast tissue. Diffuse optical imaging (DOI) is a safe (nonionizing), and relatively inexpensive method for noninvasive imaging of breast cancer in human subjects (including dense breast tissues) by providing physiological information (e.g. oxy- and deoxy- hemoglobin concentration). At the Optical Imaging Laboratory, a hand-held optical imager has been developed which employs a breast contourable probe head to perform simultaneous illumination and detection of large surfaces towards near real-time imaging of human breast cancer. Gen-1 and gen-2 versions of the handheld optical imager have been developed and previously demonstrated imaging in tissue phantoms and healthy human subjects. Herein, the hand-held optical imagers are applied towards in vivo imaging of breast cancer subjects in an attempt to determine the ability of the imager to detect breast tumors. Five female human subjects (ages 51-74) diagnosed with breast cancer were imaged with the gen-1 optical imager prior to surgical intervention. One of the subjects was also imaged with the gen-2 optical imager. Both imagers use 785 nm laser diode sources and ICCD camera detectors to generate 2D surfaces maps of total hemoglobin absorption. The subjects lay in supine position and images were collected at various locations on both the ipsilateral (tumor-containing) and contralateral (non-tumor containing) breasts. The optical images (2D surface maps of optical absorption due to total hemoglobin concentration) show regions of higher intensity at the tumor location, which is indicative of increased vasculature and higher blood content due to the presence of the tumor. Additionally, a preliminary result indicates the potential to image lymphatic spread. This study demonstrates the potential of the hand-held optical devices to noninvasively image breast cancer in human subjects.
Collapse
Affiliation(s)
- Sarah J Erickson-Bhatt
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Manuela Roman
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Jean Gonzalez
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Annie Nunez
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| | - Richard Kiszonas
- Dept. of Breast Radiology, Sylvester Comprehensive Cancer Center, 1475 N.W. 12th Ave., Miami, FL, USA 33136
| | | | - Anuradha Godavarty
- Dept. of Biomedical Engineering, Florida International University, 10555 West Flagler St. EC2610, Miami, FL, USA 33174
| |
Collapse
|
9
|
Sieno LD, Mora AD, Boso G, Tosi A, Pifferi A, Cubeddu R, Contini D. Diffuse optics using a dual window fast-gated counter. APPLIED OPTICS 2014; 53:7394-401. [PMID: 25402904 DOI: 10.1364/ao.53.007394] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
In this paper we demonstrate the advantages of a fast-gated counter in achieving high count-rate and reducing costs of timing equipment in a time-resolved diffuse optical spectroscopy setup. We experimentally prove the equivalence between the fast-gated counter we developed and a traditional time-correlated single-photon counting setup in terms of depth sensitivity and signal-to-noise ratio. Additionally, we show the suitability of this device for bilayer analysis and to estimate the absorption coefficient of homogeneous diffusing media. Finally, we present a proof-of-principle arterial occlusion measurement on a healthy volunteer to validate the proposed approach in a real application. Fast-gated counters can dramatically reduce both costs and complexity in time-resolved multichannel systems, while achieving high count-rate, thus offering a great advantage in applications like brain and muscle functional imaging.
Collapse
|
10
|
Gunadi S, Leung TS, Elwell CE, Tachtsidis I. Spatial sensitivity and penetration depth of three cerebral oxygenation monitors. BIOMEDICAL OPTICS EXPRESS 2014; 5:2896-912. [PMID: 25401006 PMCID: PMC4230856 DOI: 10.1364/boe.5.002896] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2014] [Revised: 07/16/2014] [Accepted: 07/16/2014] [Indexed: 05/03/2023]
Abstract
The spatial sensitivities of NIRO-100, ISS Oximeter and TRS-20 cerebral oxygenation monitors are mapped using the local perturbation method to inform on their penetration depths and susceptibilities to superficial contaminations. The results show that TRS-20 has the deepest mean penetration depth and is less sensitive than the other monitors to a localized absorption change in the superficial layer. However, an integration time of more than five seconds is required by the TRS-20 to achieve an acceptable level of signal-to-noise ratio, which is the poorest amongst the monitors. With the exception of NIRO-100 continuous wave method, the monitors are not significantly responsive to layer-wide absorption change that occurs in the superficial layer.
Collapse
|
11
|
Nakamiya N, Ueda S, Shigekawa T, Takeuchi H, Sano H, Hirokawa E, Shimada H, Suzuki H, Oda M, Osaki A, Saeki T. Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy. Cancer Sci 2014; 105:833-9. [PMID: 24766271 PMCID: PMC4317930 DOI: 10.1111/cas.12432] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2014] [Revised: 04/18/2014] [Accepted: 04/23/2014] [Indexed: 12/11/2022] Open
Abstract
Near-infrared diffuse optical spectroscopy (DOS) imaging can non-invasively measure tumor hemoglobin concentration using high contrast to normal tissue, thus providing vascularity and oxygenation status. We assessed the clinical usefulness of DOS imaging in primary breast cancer. In all, 118 women with a histologically confirmed diagnosis of primary malignant tumor were enrolled. All participants underwent testing using time-resolved DOS before treatment initiation. Visual assessment of DOS imaging for detecting tumors was carried out by two readers blinded to the clinical data. Relative total hemoglobin (rtHb) and oxygen saturation (stO2 ) of the tumors was compared with clinicopathological variables and 10-year prognosis was calculated. Sensitivity for detecting a tumor based on the rtHb breast map was 62.7% (74/118). The sensitivity depended on T stage: 100% (7/7) for T3, 78.9% (45/57) for T2, 44.7% (17/38) for T1, and 31.3% (5/16) for Tis . Tumors showed unique features of higher rtHb with a wider range of stO2 than normal breast tissue, depending on histological type. There was a significant correlation of rtHb with tumor size, lymphatic vascular invasion, and histological grade, and of stO2 with age and tumor size. Neither rtHb nor stO2 correlated with intrinsic biomarkers such as estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2; rtHb inversely correlated with 10-year relapse-free survival and overall survival, with statistical significance. Diffuse optical spectroscopy imaging has limited utility for the early detection of breast cancer; nonetheless, the findings suggest that the degree of tumor angiogenesis and hypoxia may be associated with tumor aggressiveness and poor prognosis.
Collapse
Affiliation(s)
- Noriko Nakamiya
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Ueda S, Kuji I, Shigekawa T, Takeuchi H, Sano H, Hirokawa E, Shimada H, Suzuki H, Oda M, Osaki A, Saeki T. Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients. PLoS One 2014; 9:e98715. [PMID: 24905225 PMCID: PMC4048242 DOI: 10.1371/journal.pone.0098715] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2013] [Accepted: 05/07/2014] [Indexed: 11/18/2022] Open
Abstract
Purpose Optical imaging techniques for measuring tissue hemoglobin concentration have been recently accepted as a way to assess tumor vascularity and oxygenation. We investigated the correlation between early optical response to single-agent bevacizumab and treatment outcome. Methods Seven patients with advanced or metastatic breast cancer were treated with single-agent bevacizumab followed by addition of weekly paclitaxel. Optical imaging of patient's breasts was performed to measure tumor total hemoglobin concentration (tHb) and oxygen saturation (stO2) at baseline and on days 1, 3, 6, 8, and 13 after the first infusion of bevacizumab. To assess early metabolic response, 2-deoxy-2-(18F)-fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT), 18F-fluoromisonidazole (FMISO)-PET/CT, and magnetic resonance imaging were performed at baseline and after two cycles of the regimen. Results Seven patients were grouped as responders (n = 4) and nonresponders (n = 3) on the basis of metabolic response measured by FDG-PET/CT. The responders showed remarkable tumor shrinkage and low accumulations of FMISO tracer relative to those of the nonresponders at the completion of two cycles of chemotherapy. Tumors of both groups showed remarkable attenuation of mean tHb as early as day 1 after therapy initiation. The nonresponders had lower baseline stO2 levels compared with adjacent breast tissue stO2 levels along with a pattern of steadily low stO2 levels during the observation window. On the other hand, the responders appeared to sustain high stO2 levels with temporal fluctuation. Conclusions Low tumor stO2 level after single-agent bevacizumab treatment was characteristic of the nonresponders. Tumor stO2 level could be a predictor of an additional benefit of bevacizumab over that provided by paclitaxel.
Collapse
Affiliation(s)
- Shigeto Ueda
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
- * E-mail:
| | - Ichiei Kuji
- Department of Nuclear Medicine, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| | - Takashi Shigekawa
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| | - Hideki Takeuchi
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| | - Hiroshi Sano
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| | - Eiko Hirokawa
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| | - Hiroko Shimada
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| | - Hiroaki Suzuki
- Central Research Laboratory, Hamamatsu Photonics K.K., Hamakita-ku, Hamamatsu, Japan
| | - Motoki Oda
- Central Research Laboratory, Hamamatsu Photonics K.K., Hamakita-ku, Hamamatsu, Japan
| | - Akihiko Osaki
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| | - Toshiaki Saeki
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan
| |
Collapse
|
13
|
Ueda S, Saeki T. Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy. Breast Cancer 2014; 21:776-9. [PMID: 24795075 DOI: 10.1007/s12282-014-0534-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2014] [Accepted: 04/07/2014] [Indexed: 01/18/2023]
Abstract
BACKGROUND Near-infrared diffuse optical imaging (DOSI) has been recently accepted as a method to assess tumor vascularity and oxygenation by measuring tissue hemoglobin (Hb) concentration. It is expected that DOSI could be used to monitor changes in vascularity after antiangiogenic therapy. METHODS A patient with advanced breast cancer was treated with single-agent bevacizumab followed by addition of weekly paclitaxel to it. DOSI was performed in the tumor-bearing breast and contralateral normal breast at baseline, 3, 6, 12, 24 h, and then daily for 1 week. Images of a tumor-to-normal ratio of tHb (rtHb) were constructed for identifying a tumor lesion. RESULTS Serial images of rtHb showed a tumor lesion which corresponded to a hot spot. The level of rtHb rapidly decreased within several hours after administration of single-agent bevacizumab and then persisted at low levels during treatment. From day 2, the value of rtHb gradually increased and peaked on day 5. CONCLUSION This trend may be explained considering sequential images of rtHb indicating the inhibition of angiogenesis due to antiangiogenic therapy. We conducted a clinical study using single-agent bevacizumab followed by neoadjuvant chemotherapy in primary breast cancer patients to understand vascular remodeling after antiangiogenic agent at very early time points using DOSI.
Collapse
Affiliation(s)
- Shigeto Ueda
- Department of Breast Oncology, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1298, Japan,
| | | |
Collapse
|
14
|
Ueda S, Nakamiya N, Matsuura K, Shigekawa T, Sano H, Hirokawa E, Shimada H, Suzuki H, Oda M, Yamashita Y, Kishino O, Kuji I, Osaki A, Saeki T. Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast. BMC Cancer 2013; 13:514. [PMID: 24176197 PMCID: PMC3817816 DOI: 10.1186/1471-2407-13-514] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2013] [Accepted: 10/28/2013] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Near-infrared optical imaging targeting the intrinsic contrast of tissue hemoglobin has emerged as a promising approach for visualization of vascularity in cancer research. We evaluated the usefulness of diffuse optical spectroscopy using time-resolved spectroscopic (TRS) measurements for functional imaging of primary breast cancer. METHODS Fifty-five consecutive TNM stage I/II patients with histologically proven invasive ductal carcinoma and operable breast tumors (<5 cm) who underwent TRS measurements were enrolled. Thirty (54.5%) patients underwent 18F-fluoro-deoxy-glucose (FDG) positron emission tomography with measurement of maximum tumor uptake. TRS was used to obtain oxyhemoglobin, deoxyhemoglobin, and total hemoglobin (tHb) levels from the lesions, surrounding normal tissue, and contralateral normal tissue. Lesions with tHb levels 20% higher than those present in normal tissue were defined as "hotspots," while others were considered "uniform." The findings in either tumor type were compared with clinicopathological factors. RESULTS "Hotspot" tumors were significantly larger (P= 0.002) and exhibited significantly more advanced TNM stage (P=0.01), higher mitotic counts (P=0.01) and higher levels of FDG uptake (P=0.0004) compared with "uniform" tumors; however, other pathological variables were not significantly different between the two groups. CONCLUSIONS Optical imaging for determination of tHb levels allowed for measurement of tumor vascularity as a function of proliferation and glucose metabolism, which may be useful for prediction of patient prognosis and potential response to treatment.
Collapse
Affiliation(s)
- Shigeto Ueda
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Noriko Nakamiya
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Kazuo Matsuura
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Takashi Shigekawa
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Hiroshi Sano
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Eiko Hirokawa
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Hiroko Shimada
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Hiroaki Suzuki
- Central Research Laboratory, Hamamatsu Photonics K.K, Hamamatsu City 434-8601, Japan
| | - Motoki Oda
- Central Research Laboratory, Hamamatsu Photonics K.K, Hamamatsu City 434-8601, Japan
| | - Yutaka Yamashita
- Central Research Laboratory, Hamamatsu Photonics K.K, Hamamatsu City 434-8601, Japan
| | - Osamu Kishino
- Central US Service, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Ichiei Kuji
- Department of Nuclear Medicine, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Akihiko Osaki
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| | - Toshiaki Saeki
- Department of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka City 350-1298, Saitama, Japan
| |
Collapse
|
15
|
Alfano RR. Advances in optical imaging in cancer research--Part 1. Technol Cancer Res Treat 2011; 10:391-2. [PMID: 21895024 PMCID: PMC4527426 DOI: 10.7785/tcrt.2012.500216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|